1/
đ Excited to share our preprint tackling a key gap in precision oncology: the lack of robust non-response biomarkers to guide clinical decisions.
These markers can spare patients from ineffective treatments and ease pressure on healthcare systems.
www.biorxiv.org/content/10.1...